Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)

China · Delayed Price · Currency is CNY

35.98

-1.22 (-3.28%)

May 12, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceuticals	662.52M	199.78M	127.84M	27.73M	16.23M
Pharmaceuticals Growth	231.62%	56.28%	361.03%	70.88%	206.03%
Total	662.52M	199.78M	127.84M	27.73M	16.23M
Total Growth	231.62%	56.28%	361.03%	70.88%	206.03%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Mainland China	582.13M	-	-	-	16.23M
Mainland China Growth	-	-	-	-	206.03%
Other Regions	80.38M	-	-	-	-
Total	662.52M	-	-	-	16.23M
Total Growth	-	-	-	-	206.03%

Source: S&P Global Market Intelligence.